Prelude Capital Management’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Prelude Capital Management’s Portfolio SHAC Stock Details SHAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-201,000	Closed	-$1.98M	–	1864
2022 Q3	$1.98M	Hold	201,000	–	–	0.07%	238
2022 Q2	$1.98M	Hold	201,000	–	–	0.06%	303
2022 Q1	$1.97M	Hold	201,000	–	–	0.06%	348
2021 Q4	$1.97M	Sell	201,000 -3,626	-2%	-$35.4K	0.05%	327
2021 Q3	$1.99M	Buy	204,626 +3,626	+2%	+$35.1K	0.05%	307
2021 Q2	$1.95M	Buy	+201,000	New	+$1.95M	0.06%	311

Prelude Capital Management's SHAC Position: Q4 2022 in Review

Prelude Capital Management sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 201,000 shares — an estimated $1.98M sold.

Prelude Capital Management first reported a position in SHAC in Q2 2021 and held it in 6 quarters. The position peaked at $1.99M in Q3 2021. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

Prelude Capital Management reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Prelude Capital Management sold 201,000 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $1.98M.
Prelude Capital Management first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q2 2021 and held it in 6 quarters.
Prelude Capital Management's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $1.99M in Q3 2021.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.